CXCL10 and Alzheimer disease: Notably, human CXCL10 levels are increased in progranulin-linked FTD (81), AD (113), and amnestic mild cognitive impairment (113), either in the cerebrospinal fluid or in astrocytes (62), and these levels correlate with cognitive performance (113).